en
Scientific article
Open access
English

The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children

Published inPloS one, vol. 8, no. 8, e72141
Publication date2013
Abstract

Preformed anti-HLA antibodies (AHA) are known to be associated with delayed engraftment and reduced overall survival after adult hematopoietic stem cell transplantation. However, limited data is available in pediatric patients. In this study, we explored the role of AHA on clinical outcomes in 70 pediatric patients who received a single unit of HLA mismatch cord blood for hematologic malignancies, immunodeficiencies or metabolic diseases. The presence of AHA was detected in 44% (31/70) of the patients. Preformed class I AHA was associated with an increased occurrence of grade 1-4 acute graft-versus host disease (p<0.05). The presence of anti- major-histocompatibility-complex class I-related chain A antigens (MICA) antibodies was significantly associated with a reduced platelet recovery after transplantation (p<0.05). AHA of class II with the strength of antibody titer measured as the mean fluorescence intensity above 2000 was associated with reduced event-free survival (p<0.05). A reduction of high titer of AHA and anti-MICA antibodies might have to be considered before cord blood transplantation in pediatric patients for better outcomes.

Citation (ISO format)
ANSARI DJABERI, Marc Georges et al. The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children. In: PloS one, 2013, vol. 8, n° 8, p. e72141. doi: 10.1371/journal.pone.0072141
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1932-6203
619views
350downloads

Technical informations

Creation02/27/2014 11:27:00 AM
First validation02/27/2014 11:27:00 AM
Update time03/14/2023 9:07:10 PM
Status update03/14/2023 9:07:09 PM
Last indexation05/02/2024 3:03:52 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack